EUCTR2005-001267-63-IT进行中（未招募）不适用
A PHASE I BRIDGING STUDY USING CH14.18/CHO ANTIBODY IN CHILDREN WITH REFRACTORY NEUROBLASTOMA (NB)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Feasibility study using an antibody against neuroblastoma after stem cell transplantatioPediatric patients with relapsed neuroblastomaMedDRA version: 18.0Level: PTClassification code 10066595Term: Neuroblastoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-015936-14-DEniversity Children´s Hospital Tübingen,60
进行中（未招募）
1 期
Study investigating the feasibility of using an antibody (ch14.18/CHO) directed against neuroblastoma and the cyctokine IL2 in the treatment of relapsed neuroblastoma patients after haploidentical stem cell transplantatioPediatric patients with relapsed neuroblastomaMedDRA version: 19.1Level: PTClassification code 10066595Term: Neuroblastoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-015936-14-ATniversity Children´s Hospital Tübingen,35
进行中（未招募）
不适用
Bridging study using ch14.18/CHO antibody in children with refractory neuroblastomaneuroblastomaEUCTR2005-001267-63-ATSt. Anna Kinderspital18
进行中（未招募）
1 期
PHASE II STUDY OF CH14.18/CHO IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED NEUROBLASTOMAPRIMARY REFRACTORY OR RELAPSED NEUROBLASTOMAMedDRA version: 20.0Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-000588-42-DEMedical University Greifswald40
进行中（未招募）
1 期
PHASE II STUDY OF CH14.18/CHO IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED NEUROBLASTOMAEUCTR2014-000588-42-ATMedical University Greifswald40